| Ident. | Authors (with country if any) | Title |
|---|
| 000120 (2005) |
Moussa B. H. Youdim [Israël] ; Orit Bar Am [Israël] ; Merav Yogev-Falach [Israël] ; Orly Weinreb [Israël] ; Wakako Maruyama [Japon] ; Makato Naoi [Japon] ; Tamar Amit [Israël] | Rasagiline: Neurodegeneration, neuroprotection, and mitochondrial permeability transition |
| 000146 (2000) |
George A. Veech [États-Unis] ; Jameel Dennis [États-Unis] ; Paula M. Keeney [États-Unis] ; Christopher P. Fall [États-Unis] ; Russell H. Swerdlow [États-Unis] ; W. Davis Parker Jr. [États-Unis] ; James P. Bennett Jr. [États-Unis] | Disrupted mitochondrial electron transport function increases expression of anti‐apoptotic Bcl‐2 and Bcl‐XL proteins in SH‐SY5Y neuroblastoma and in Parkinson disease cybrid cells through oxidative stress |
| 000344 (2001) |
Nadia Stefanova [Autriche, Bulgarie] ; Lars Klimaschewski [Autriche] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche] ; Markus Reindl [Autriche] | Glial cell death induced by overexpression of α‐synuclein |
| 000633 (1992) |
L. Lorigados [Suède, Cuba] ; S. Söderström [Suède] ; T. Ebendal [Suède] | Two‐site enzyme immunoassay for βNGF applied to human patient sera |
| 000642 (2009) |
Payal N. Gandhi [États-Unis] ; Shu G. Chen [États-Unis] ; Amy L. Wilson-Delfosse [États-Unis] | Leucine‐rich repeat kinase 2 (LRRK2): A key player in the pathogenesis of Parkinson's disease |
| 000764 (2009) |
Anna G Mez [Espagne] ; Isidre Ferrer [Espagne] | Increased oxidation of certain glycolysis and energy metabolism enzymes in the frontal cortex in Lewy body diseases |
| 000B28 (1996) |
S. Kösel [Allemagne] ; C. B. Lücking [Allemagne] ; R. Egensperger [Allemagne] ; P. Mehraein [Allemagne] ; M. B. Graeber [Allemagne] | Mitochondrial NADH dehydrogenase and CYP2D6 genotypes in Lewy‐body Parkinsonism |
| 000B46 (2002) |
Nicole A. Abramova [États-Unis] ; David S. Cassarino [États-Unis] ; Shaharyar M. Khan [États-Unis] ; Terry W. Painter [États-Unis] ; James P. Bennett Jr. [États-Unis] | Inhibition by R(+) or S(–) pramipexole of caspase activation and cell death induced by methylpyridinium ion or beta amyloid peptide in SH‐SY5Y neuroblastoma |
| 000C21 (1990) |
R. F. Peppard ; W. R. W. Martin ; C. M. Clark ; G. D. Carr ; P. L. Mcgeer ; D. B. Calne | Cortical glucose metabolism in parkinson's and alzheimer's disease |
| 000C58 (2008) |
Yi Wei Lu [Singapour] ; Eng-King Tan [Singapour] | Molecular biology changes associated with LRRK2 mutations in Parkinson's disease |
| 000D42 (2001) |
Ferda Yantiri [États-Unis] ; Anna Gasparyan [États-Unis] ; Julie K. Andersen [États-Unis] | Glutamyl cysteine synthetase catalytic and regulatory subunits localize to dopaminergic nigral neurons as well as to astrocytes |
| 000D58 (2010) |
Aleksandra Glavaski-Joksimovic [États-Unis] ; Tamas Virag [États-Unis] ; Thomas A. Mangatu [États-Unis] ; Michael Mcgrogan [États-Unis] ; Xue Song Wang [États-Unis] ; Martha C. Bohn [États-Unis] | Glial cell line‐derived neurotrophic factor–secreting genetically modified human bone marrow‐derived mesenchymal stem cells promote recovery in a rat model of Parkinson's disease |
| 001046 (2007) |
Kenjiro Ono [Japon] ; Mie Hirohata [Japon] ; Masahito Yamada [Japon] | Anti‐fibrillogenic and fibril‐destabilizing activities of anti‐Parkinsonian agents for α‐synuclein fibrils in vitro |
| 001051 (2007) |
Linda R. White [Norvège] ; Mathias Toft [Norvège] ; Sylvia N. Kvam [Norvège] ; Matthew J. Farrer [États-Unis] ; Jan O. Aasly [Norvège] | MAPK‐pathway activity, Lrrk2 G2019S, and Parkinson's disease |
| 001147 (2000) |
Mari G Rseth [Norvège] ; Ursula Sonnewald [Norvège] ; Linda R. White [Norvège] ; Marianne R D [Norvège] ; John-Anker Zwart [Norvège] ; Ystein Nygaard [Norvège] ; Jan Aasly [Norvège] | Proton magnetic resonance spectroscopy of cerebrospinal fluid in neurodegenerative disease: Indication of glial energy impairment in Huntington chorea, but not Parkinson disease |
| 001245 (2001) |
Rosario Sánchez-Pernaute [États-Unis] ; Lorenz Studer [États-Unis] ; Krys S. Bankiewicz [États-Unis] ; Eugene O. Major [États-Unis] ; Ronald D. G. Mckay [États-Unis] | In vitro generation and transplantation of precursor‐derived human dopamine neurons |
| 001275 (2009) |
Michaela Hahn [Allemagne] ; Marco Timmer [Allemagne] ; Guido Nikkhah [Allemagne] | Survival and early functional integration of dopaminergic progenitor cells following transplantation in a rat model of Parkinson's disease |
| 001307 (2000) |
I. Lamensdorf [États-Unis] ; G. Eisenhofer [États-Unis] ; J. Harvey-White [États-Unis] ; Y. Hayakawa [États-Unis] ; K. Kirk [États-Unis] ; I. J. Kopin [États-Unis] | Metabolic stress in PC12 cells induces the formation of the endogenous dopaminergic neurotoxin, 3,4‐dihydroxyphenylacetaldehyde |
| 001441 (2011) |
Natalie R. S. Goldberg [États-Unis] ; Tom Hampton [États-Unis] ; Scott Mccue [États-Unis] ; Ajit Kale [États-Unis] ; Charles K. Meshul [États-Unis] | Profiling changes in gait dynamics resulting from progressive 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced nigrostriatal lesioning |
| 001490 (2002) |
V. Calabrese [Italie] ; G. Scapagnini [Italie, États-Unis] ; A. Ravagna [Italie] ; R. G. Fariello [États-Unis, Italie] ; A. M. Giuffrida Stella [Italie] ; N. G. Abraham [États-Unis] | Regional distribution of heme oxygenase, HSP70, and glutathione in brain: Relevance for endogenous oxidant/antioxidant balance and stress tolerance |
| 001544 (2010) |
Ruth H. Walker [États-Unis] ; Georgia Davies [États-Unis] ; Rick J. Koch [États-Unis] ; Andrew K. Haack [États-Unis] ; Cynthia Moore [États-Unis] ; Charles K. Meshul [États-Unis] | Effects of zona incerta lesions on striatal neurochemistry and behavioral asymmetry in 6‐hydroxydopamine‐lesioned rats |
